Outset Medical Inc (OM)
Outset Medical, Inc. is a healthcare technology company listed on NASDAQ under the symbol OM. The company focuses on developing hemodialysis technology in the United States, centered on its Tablo Hemodialysis System. Tablo is designed as a compact console with integrated water purification, on-demand dialysate production, and software and connectivity features. Outset Medical also manufactures, supports, and distributes the Tablo console, Tablo cartridges, and related consumables. In addition, it provides the Tablo Data Ecosystem, which includes TabloHub, a consumer-facing portal, MyTablo, a patient-facing portal, and TabloDash, an internal analytics platform. Founded in 2003 and headquartered in San Jose, California, the company was previously known as Home Dialysis Plus, Ltd. before adopting its current name in 2015.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-OM
|
$4.50
|
36.9% Upside
|
Undervalued
|
$7.67
|
133.0% Upside
|
Bargain
|
Fair
|
0.0%
|
November 10, 2026
|
0.6x
|
0.5x
|
61.843 M
|
15.902 M
|
64.0%
|
78.6%
|
-6.2
|
52.3%
|
